SPRO Investor Update: Robbins LLP Reminds Shareholders Lead
SAN DIEGO, June 11, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action...
United States Aaron Dumas Securities Exchange Drug Administration Spero Therapeutics Inc Spero Therapeutics
Source: globenewswire.com